Topical Ocular Povidone-Iodine as an Adjunctive Preventative Practice in the Era of COVID-19.
Asia Pac J Ophthalmol (Phila) 2021;
10:142-145. [PMID:
33793439 PMCID:
PMC8016473 DOI:
10.1097/apo.0000000000000353]
[Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2020] [Accepted: 11/08/2020] [Indexed: 12/24/2022] Open
Abstract
ABSTRACT
Ophthalmologists and patients have an inherent increased risk for transmission of SARS-CoV-2. The human ocular surface expresses receptors and enzymes facilitating transmission of SARS-CoV-2. Personal protective equipment alone provides incomplete protection. Adjunctive topical ocular, nasal, and oral antisepsis with povidone iodine bolsters personal protective equipment in prevention of provider-patient transmission of SARS-CoV-2 in ophthalmology.
Collapse